Skip to main content

Table 1 Data of 11 HAE patients gathered from chart review including demographics, comorbidities, HAE type and time of diagnosis

From: Impact of lanadelumab in hereditary angioedema: a case series of 12 patients in Canada

Case Age Sex HAE Type Comorbidities Other medications Age symptom onset (years) Age HAE diagnosis (years)
1 25 M 1 Nil Nil 18 18
2 24 M 1 Nil Nil 1 4
3 42 F 1 SLE (quiescent) Nil 10 23
4 38 F 2 Nil Nil 11 2
5 36 F 1 Ulcerative Colitis Nil 4 12
6 30 F 1 GERD, Chronic Pain Methadone 23 25
7 59 F 1 Nil Nil 26 59
8 34 F 1 Depression Citalopram 11 11
9 50 F 1 Nil Nil 47 48
10 74 F 1 Multiple Myeloma, HTN Revlimid, Telmisartan Unknown 55
11 44 F 1 Raynaud’s, GERD, Cervical Stenosis Esomeprazole 15 33
12 65 M 1 T1DM, Primary Adrenal Insufficiency Insulin
Pantoprazole
37 37
  1. GERD gastroesophageal reflux disease, SLE systemic lupus erythematosus, HTN hypertension, T1DM type 1 diabetes